Abstract
Preliminary studies have suggested that the intracavitary administration of cytokines may represent a new effective palliative therapy of malignant effusions. To define further the therapeutic role of cytokines in the treatment of neoplastic fluid accumulation, 70 cancer patients with pleural, pericardial or peritoneal cytologically proven neoplastic effusions were randomized to receive intracavitary cycles with interleukin-2 (IL-2; 6x106 IU), interferon (IFNα; 2x107 U) or IFNβ (6x106 U) every week for 2 or 3 weeks. A clinical control of fluid accumulation was obtained in 39/70 (56%) patients. In patients with mesothelioma, the response rate was significantly higher with IL-2 than with IFNα or-β, while there was no difference in patients with tumors other than mesothelioma. Moreover, the duration of the period during which drainage was not required was significantly longer in patients treated with Il-2 than in the other groups. Toxicity was low in all patients. According to preliminary data, this study demonstrates that intracavitary administration of cytokines, including IL-2, IFNα and-β, is a new well-tolerated palliative therapy for malignant effusions, with an efficacy substantially comparable to that described with the most commonly used treatments with tetracyclines or cytostatic agents.
References
Atzpodien J, Kirchner H (1990) Cancer, cytokines and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 68:1–11
Austin EH, Fly W (1979) The treatment of recurrent malignant pleural effusion. Ann Thorac Surg 28:190–194
Barni S, Lissoni P, Cattaneo G, et al (1990) Interferon-alpha 2b in the treatment of pleural and peritoneal neoplastic effusions. J Cancer Res Clin Oncol 116 [Suppl]:306
Paladine W, Cunningham TJ, Sponzo R, et al (1976) Intracavitary bleomycin in the management of malignant effusions. Cancer 38:1903–1908
Wallach HW (1975) Intrapleural tetracycline for malignant pleural effusions. Chest 68:510–515
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lissoni, P., Barni, S., Tancini, G. et al. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon α, β and interleukin-2. Support Care Cancer 3, 78–80 (1995). https://doi.org/10.1007/BF00343925
Issue Date:
DOI: https://doi.org/10.1007/BF00343925